Breaking News

Gemini Bio Wins Federal Contract to Support COVID-19 Testing

Will be increasing domestic production of reagents from its California facility, as well as its manufacturing footprint

By: Contract Pharma

Contract Pharma Staff

Gemini Bio has been awarded a federal government contract to supply critical products in efforts to support COVID-19 testing. Gemini Bio is focused on supporting agencies and labs in four key areas: cell culture, viral harvesting and transport, research tools, and analytical instruments.   Gemini Bioproducts, a supplier of cell culture solutions, has received a federal government contract award to supply critical products in support of the high demand for COVID-19 testing.   Gemini Bio will be s...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters